Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
Mbiye A Mpenge,1 Alasdair P MacGowan2 1Department of Medical Microbiology, University Hospitals Bristol NHS Trust, Bristol Royal Infirmary, Bristol, England; 2Department of Medical Microbiology, North Bristol NHS Trust, Southmead Hospital, Bristol, England Abstract: Ceftaroline is a new parenteral c...
Saved in:
Main Authors: | Mpenge MA (Author), MacGowan AP (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
by: Goodman JJ, et al.
Published: (2012) -
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
by: Maggiore C, et al.
Published: (2015) -
The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
by: Phylinda L.S. Chan, et al.
Published: (2021) -
In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019-2020
by: Alona Kuraieva, et al.
Published: (2023) -
Current role of community-acquired methicillin-resistant Staphylococcus aureus among children with skin and soft tissue infections
by: Carlos G. Teran, et al.
Published: (2012)